Nuclear Imaging Devices Market to Reach USD 6.2 Billion by 2034

Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the Global Nuclear Imaging Devices Market is valued at USD 4.1 billion in 2024 and is projected to reach USD 6.2 billion by 2034, growing at a CAGR of 4.2% from 2025 to 2034. The increasing use of molecular imaging for oncology and cardiology diagnostics, along with rapid advancements in PET, SPECT, and hybrid imaging technologies, continues to fuel the market's growth worldwide.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49316

Key Takeaways
• Market Size (2024): USD 4.1 Billion
• Forecast (2034): USD 6.2 Billion
• CAGR (2025-2034): 4.2%
• Major Growth Drivers: Rising incidence of cancer and cardiovascular diseases, growing use of PET/CT and SPECT/CT systems, and integration of artificial intelligence (AI) for image analysis.
• Leading Companies: Siemens Healthineers AG, GE HealthCare Technologies Inc., Canon Medical Systems Corporation, Philips Healthcare, Mediso Medical Imaging Systems, Neusoft Medical Systems, and Positron Corporation.

Market Story
The Nuclear Imaging Devices Market plays a pivotal role in modern diagnostic medicine by providing precise functional and anatomical insights at the molecular level. Nuclear imaging technologies-such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT)-enable early detection and monitoring of cancers, heart diseases, neurological disorders, and metabolic conditions.

Over the past decade, the market has witnessed a paradigm shift toward hybrid imaging systems (PET/CT, PET/MRI, and SPECT/CT), which combine anatomical precision with metabolic data, enhancing diagnostic accuracy. The integration of AI and machine learning algorithms has further improved image reconstruction, noise reduction, and predictive analytics in radiology workflows.
Growing investments in radiopharmaceutical R&D, coupled with government funding for advanced imaging infrastructure, continue to strengthen global adoption. Emerging markets are now rapidly modernizing their healthcare systems to expand nuclear imaging capacity and reduce diagnostic delays.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49316/nuclear-imaging-devices-market

Market Segmentation
By Product Type:
• PET (Positron Emission Tomography) Systems
• SPECT (Single Photon Emission Computed Tomography) Systems
• Hybrid Imaging Systems (PET/CT, PET/MRI, SPECT/CT)
• Planar Scintigraphy Systems

By Application:
• Oncology
• Cardiology
• Neurology
• Others (Orthopedic, Gastrointestinal, Endocrinology)

By End-User:
• Hospitals
• Diagnostic Imaging Centers
• Research Institutes
• Specialty Clinics

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments
• 2025: Siemens Healthineers launched its Biograph Vision Quadra PET/CT system, enhancing field-of-view and time-of-flight imaging for oncology applications.
• 2024: GE HealthCare introduced its AI-assisted molecular imaging platform for precision oncology and cardiology diagnostics.
• 2024: Canon Medical Systems unveiled a next-generation SPECT/CT system with improved photon sensitivity and faster reconstruction.
• 2023: Philips Healthcare expanded its digital PET portfolio, integrating cloud-based image analytics for early-stage disease detection.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49316

Expert Insight
"The combination of AI, molecular imaging, and hybrid modalities is redefining how clinicians diagnose and monitor diseases," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"Nuclear imaging devices are no longer just diagnostic tools-they are becoming the foundation of precision medicine and data-driven clinical decisions."

Regional Outlook
• North America leads the global market with more than 40% share, supported by early technology adoption, reimbursement availability, and strong research networks.
• Europe follows with increased investment in hybrid imaging and radiopharmaceutical production facilities.
• Asia Pacific is expected to grow at the fastest rate (CAGR above 5.5%), driven by healthcare modernization, government funding, and expanding diagnostic capacity in India, China, and Japan.
• Latin America & Middle East are emerging markets with improving nuclear medicine infrastructure and growing training initiatives.

Conclusion
The Nuclear Imaging Devices Market is transitioning toward high-precision, AI-assisted molecular imaging that enables early and accurate diagnosis. With increasing global healthcare expenditure and the expansion of hybrid imaging facilities, the next decade will witness widespread adoption of digital and cloud-integrated nuclear imaging technologies that elevate diagnostic and therapeutic outcomes.

This report is also available in the following languages : Japanese (核イメージング装置), Korean (핵의학 영상 장치), Chinese (核成像设备), French (Dispositifs d'imagerie nucléaire), German (Nuklearmedizinische Bildgebungsgeräte), and Italian (Dispositivi di imaging nucleare), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49316

Our More Reports:

Pain Patch Market
https://exactitudeconsultancy.com/reports/49872/pain-patch-market

Antibiotic Resistance Market
https://exactitudeconsultancy.com/reports/49874/antibiotic-resistance-market

Cardiac Biomarkers Market
https://exactitudeconsultancy.com/reports/49877/cardiac-biomarkers-market

Medical Drones Market
https://exactitudeconsultancy.com/reports/65801/medical-drones-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.